Autori: Andric Zoran G
| Naslov | Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 (Meeting Abstract) |
| Autori | Herbst Roy S ... Andric Zoran G ... (broj koautora 21) |
| Info | SWISS MEDICAL WEEKLY, (2020), vol. br. , Suppl. 247, str. 31S-32S |
| Projekat | F. Hoffmann-La Roche, Ltd.Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924 (Meeting Abstract) |
| Autori | Andric Zoran G Ceric Timur Stanetic Mirko Rancic Milan H Jakopovic Marko Aix S Ponce Ramlau Rodryg Smit E Ulanska M Caldwell C Ferrari D Annis A Vukovic V Zaric Bojan |
| Info | EUROPEAN JOURNAL OF CANCER, (2020), vol. 138 br. , Suppl. 2, str. S5-S5 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Assessment of age-related influences on the quality of life of breast cancer patients before and after surgical treatment (Article) |
| Autori | Kostic Sanja V Murtezani Zafir Andric Zoran G Ivanovic Nebojsa S Kozomara Zoran K Kostic Marko I Milicic Vesna M Kocic Sanja S |
| Info | VOJNOSANITETSKI PREGLED, (2020), vol. 77 br. 9, str. 908-916 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC (Article) |
| Autori | Herbst Roy S ... Andric Zoran G ... (broj koautora 22) |
| Info | NEW ENGLAND JOURNAL OF MEDICINE, (2020), vol. 383 br. 14, str. 1328-1339 |
| Projekat | Roche HoldingGenentech; IMpower110 ClinicalTrials.gov number [NCT02409342] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study. (Meeting Abstract) |
| Autori | Millan Susana Trukhin Dmytro Kolesnik Oleksii Poddubskaya Elena Andric Zoran G Bondarenko Igor N Shevnia Serhii Bullo Felicitas Sarnago Cristina |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 15, Suppl. S, str. - |
| Projekat | mAbxience Research SI |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Myelopreservation and reduced use of supportive care with trilaciclib in patients with small cell lung cancer. (Meeting Abstract) |
| Autori | Jared Weiss Jerome Goldschmidt Andric Zoran G Konstantin Dragnev H Yili Pritchett Shannon Morris R Rajesh Malik K Davey Daniel B |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 15, Suppl. S, str. - |
| Projekat | G1 Therapeutics, Inc. |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Impower110: Interim Overall Survival (OS) Analysis of a Phase Iii Study of Atezolizumab (Atezo) Monotherapy Vs Platinum-Based Chemotherapy (Chemo) as First-Line (1L) Treatment in PD-L1-Selected NSCLC (Meeting Abstract) |
| Autori | Herbst Roy S ... Andric Zoran G ... (broj koautora 20) |
| Info | JOURNAL FOR IMMUNOTHERAPY OF CANCER, (2020), vol. 8 br. , Suppl. 1, str. A1-A1 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Impower110: Interim OS Analysis of a Phase III Study Of Atezolizumab (ATEZO) vs Platinum-Based Chemotherapy (Chemo) as 1L Treatment (TX) in PD-L1-Selected NSCLC (Meeting Abstract) |
| Autori | Reinmuth Niels ... Andric Zoran G ... (broj koautora 20) |
| Info | ONCOLOGY RESEARCH AND TREATMENT, (2020), vol. 43 br. , Suppl. 1, str. 232-233 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial (Article) |
| Autori | Mansfield AS ... Andric Zoran G ... (broj koautora 19) |
| Info | ANNALS OF ONCOLOGY, (2020), vol. 31 br. 2, str. 310-317 |
| Projekat | F. Hoffmann-La Roche Ltd, Basel, SwitzerlandHoffmann-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Hypertension in Polycystic Ovary Syndrome: Novel Insights (Review) |
| Autori | Macut Djuro P Mladenovic Violeta S Bjekic-Macut Jelica D Livadas Sarantis Stanojlovic Olivera P Hrncic Dragan R Rasic-Markovic Aleksandra Vojnovic-Milutinovic Danijela D Andric Zoran G |
| Info | CURRENT HYPERTENSION REVIEWS, (2020), vol. 16 br. 1, str. 55-60 |
| Projekat | Serbian Ministry of Education, Science and Technological Development [41009, 175032] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
